Large human trials (such as the SUSTAIN and STEP programs) have not shown meaningful increases in fracture risk or significant reductions in bone mineral density directly attributable to semaglutide use
Ask the representative about specific details about coverage for Zepbound for weight loss, including coinsurance, copays, restrictions, and prior authorization requests
Dave Knapp Jan 16 2 min read Originally posted on obesity.news on January 15th, 2026 Eli Lilly has secured FDA approval for multi use vials of both Zepbound and Mounjaro, according to newly updated package inserts reviewed by On The Pen
Only India has this crazy combination, Damisetty says, adding that the result is a nightmare
Movement matters, but timing and type are flexible